Loma Linda University
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Loma Linda University sits in the top decile of US sponsors by registered trial count (#138 of 15,742 sponsors by registered trial count).
Loma Linda University: 237 sponsored US clinical trials, 35 recruiting.
Loma Linda University sponsors 237 registered US clinical trials on ClinicalTrials.gov, 35 of them currently recruiting, and 154 completed. 22 of these trials are in Phase 3-4 (later-stage) and 14 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Inflammation, with 4 trials.
Top-decile sponsor footprint
Loma Linda University ranks in the top decile of sponsors by registered trial count (#138 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
154 of 186 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
237 total, page 1 of 5
Impact of Lactation Antenatal Teaching by Clinicians and Healthcare Providers
NCT07560553
Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement
NCT04527445
Patient Reported Experiences With Sparing External Oblique Fascia Vs Standard Inguinal Orchiectomy
NCT06828185
Strain-Counterstrain Treatment of Piriformis Pain
NCT05023005
Blood Flow Restriction Training as a Targeted Intervention for Rowers With Back Pain.
NCT07130812
To Evaluate the Preliminary Efficacy of Our Digitally Enhanced CHW-led Intervention in Newly Diagnosed PDAC
NCT07591571
Occupational Therapy for Adults Who Have Experienced Intimate Partner Violence (IPV)
NCT06808828
The Effects of Endotracheal Suctioning on Pain and Serum Markers
NCT06692400
Median Versus Ulnar Nerve Quantitative Electromyography Neuromuscular Blockade Monitoring Comparison
NCT06553131
Wound Irrigation With Saline Versus Hypodilute-chlorhexidine After Cesarean Section (WISHES Study)
NCT06339203
Diluted Aqueous Povidone-Iodine Compared to Saline to Decrease Surgical Site Infections
NCT06363877
Short-term Circuit Training on Muscle Mass and Quality of Life in Sedentary Postmenopausal Women
NCT06445842
Integrating CHWs Into Prenatal Care for Maternal Smoking Cessation
NCT06438549
Peri-implant Mucosal Changes Over Time Following Implant Provisional Removal in the Esthetic Zone
NCT06783595
Intermittent Fasting on Body Fat and Quality of Life
NCT06307275
A Physiologic Comparison of Two Approaches to Treating Peripheral Neuropathy
NCT05577390
Factors That Affect Trust Between Physicians and Patients
NCT06125431
Sleep and Central Auditory Processing Disorder in Autism Spectrum Disorder
NCT06059352
Teamwork Makes the Dream Work
NCT05866523
Stroke Rate in Patients With Blunt Cerebrovascular Injury (BCVI) Treated With Oral Acetylsalicylic Acid (ASA) 81 mg Versus ASA 325 mg (BASA).
NCT05868525
Resilience Programming for Occupational Therapy Students
NCT05956756
Lateral Pharyngoplasty Outcomes in Children Undergoing Tonsillectomy
NCT05575401
Safest Choice of Antihypertensive Regimen for Postpartum Hypertension
NCT05551104
Metabolic Cost of Walking With Passive vs. Powered Prosthetic Knees Among Persons With Limb Loss
NCT05831696
Building Resilient Families
NCT05388864
Effect of Magnesium Sulfate Bolus on Intraoperative Neuromonitoring
NCT04938765
Limited Ankle Dorsiflexion and Effect on Single Limb Squats in Individuals With Patellofemoral Pain
NCT05285007
Neural Basis of Social Cognition Deficits
NCT05185128
Melatonin Adolescent Research Study
NCT04588233
Efficacy of Preoperative Administration of Gabapentin in 3rd Molar Dental Extraction.
NCT04860141
Dd-cfDNA and Treg in Prediction of Kidney Transplant Acute Rejection
NCT05084768
Biomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With Edaravone
NCT04097158
Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer
NCT03492671
Proton Therapy for Esophageal Cancer
NCT01684904
Proton Therapy in the Treatment of Liver Metastases
NCT01697371
Continuous Glucose Monitoring: A Pilot Study
NCT06614127
Assessment of Diagnostic Adequacy of AI-assisted Point-of-Care Echocardiography Among Anesthesiology Trainees
NCT06548373
The Effects of Fresh Mango Consumption on Cardiometabolic Outcomes in Free-living Individuals With Prediabetes
NCT06159543
Does Personality Predict Patient Adherence, Health Behaviors, and Weight Loss Outcomes During the Latino Crossover Semaglutide Study (LCSS)? (Story-LCSS Project)
NCT05622045
Hepatitis C Virus (HCV) Positive Kidney Grafts in HCV Negative Recipients
NCT04605679
SCP vs HUSLS for Pelvic Organ Prolapse Repair
NCT02800512
Partial Breast Proton Therapy for Early Stage Breast Cancer
NCT01310530
Plant-based Diets and Risk of Cancer in the Adventist Health Study-2
NCT03615599
Effectiveness of Toothpaste Tablets on Plaque, Gingival Health and Caries Experiences
NCT07124533
Immune and Cognitive Benefits of Mango Intake in Young Adults
NCT06229262
Combined Circulatory and Dietary Interventions for Neuropathy
NCT07213843
The Effects of Mango on Gut Health Markers
NCT07559604
Percutaneous Cryoablation of Intercostal Nerves for the Treatment of Rib Fractures
NCT06533904
Emotional Brain Training for Addiction Medicine Treatment - A Pilot Study
NCT07001371
ADINA vs. High Flow Nasal Cannula Comparison Study
NCT03171129
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 7 |
| Phase 2 | 7 |
| Phase 3 | 12 |
| Phase 4 | 10 |
Therapeutic Areas
Where Loma Linda University enrollment is open (later-stage tilt)
35 recruiting of 237 indexed (15% open); 154 completed (65%).
Phase mix: 22 late (III/IV) vs 14 early (I/II) (later-stage heavy).
Top condition: Inflammation (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Loma Linda University: open-pipeline peers nationwide
Peers matched on 237 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Loma Linda University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 237 trials (± recruiting share)
- Daiichi Sankyo · 236 trials · 12% recruiting
- Incyte Corporation · 239 trials · 15% recruiting
- University of Massachusetts, Worcester · 240 trials · 13% recruiting
- Henry Ford Health System · 234 trials · 18% recruiting
Sponsors near 15% open enrollment (± trial volume)
- University of Rochester · 15% recruiting · 636 trials
- Dompé Farmaceutici S.p.A · 15% recruiting · 27 trials
- Vanderbilt-Ingram Cancer Center · 15% recruiting · 189 trials
- Brown University · 15% recruiting · 231 trials
Related
What to do with this Loma Linda University page
237 registered trials is a research-attention snapshot, not an endorsement of Loma Linda University or any single study.
- 35 of Loma Linda University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Inflammation is the condition Loma Linda University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Inflammation trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Loma Linda University pipeline card: 237 registered trials from official public datasets.Report a data error.